Journal
STEM CELL RESEARCH
Volume 17, Issue 3, Pages 646-653Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.scr.2016.11.015
Keywords
BMP4; Simvastatin; Marrow adipogenesis; Bone marrow cells; PPAR-gamma; Irradiation; Hematopoietic recovery
Funding
- Department of Biotechnology, Government of India, New Delhi [BT/PR11155/MED/31/44/2008]
- NCCS
- Council of Scientific and Industrial Research, Government of India, New Delhi
Ask authors/readers for more resources
Pre-transplant myeloablation is associated with marrow adipogenesis, resulting in delayed engraftment of hematopoietic stem cells (HSCs). This is strongly undesirable, especially when the donor HSCs are fewer in numbers or have compromised functionality. The molecular mechanisms behind irradiation-induced marrow adipogenesis have not been extensively investigated. Here we show that bone marrow (BM) cells, especially T-cells and stromal cells, express and secrete copious amounts of BMP4 in response to irradiation, which causes the bone marrow stromal cells to commit to adipocyte lineage, thereby contributing to an increase in bone marrow adipogenesis. We further demonstrate that Simvastatin inhibits the BMP4-mediated adipogenic commitment of marrow stromal cells by inhibiting Ppar-gamma expression. Importantly, Simvastatin does not prevent BMP4 secretion by the BM cells, and thus does not interfere with its salutary role in post-transplant hematopoietic regeneration. Our data identify previously unknown mechanisms operative in marrow adipogenesis post-myeloablation. They also reveal the molecular mechanisms behind the advantage of using Simvastatin as a niche-targeting agent to improve HSC engraftment. (C) 2016 The Authors. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available